Scope Fluidics S.A. (WSE:SCP)
114.00
-4.80 (-4.04%)
May 18, 2026, 11:04 AM CET
Scope Fluidics Company Description
Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare.
It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.
Scope Fluidics S.A.
| Country | Poland |
| Founded | 2010 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 132 |
| CEO | Piotr Garstecki |
Contact Details
Address: Ogrodowa 58 Street Warsaw Poland | |
| Phone | 48 22 376 2114 |
Stock Details
| Ticker Symbol | SCP |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLSCPFL00018 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Piotr Garstecki | Chairman of the Management Board |
| Marcin Izydorzak | Vice President of the Management Board |
| Szymon Michal Ruta | Vice-President of the Management Board and Financial Director |